HeartSciences Establishes Exclusive ECG Education Partnership with UK University

HeartSciences Inc. (NASDAQ: HSCS; HSCSW), a healthcare information technology company advancing electrocardiography through artificial intelligence integration, announced that the University of the West of England has adopted its MyoVista Insights platform and MyoVista wavECG device as exclusive ECG technologies to establish an ECG Education and Technology Reference Center. Under the agreement, the technologies will be used across UWE's cardiac and physiological science programs to train future cardiac scientists, creating a nationally aligned academic reference site that supports clinical adoption discussions with NHS trusts, validates MyoVista Insights in education and research settings, and strengthens the company's long-term commercial positioning within the UK healthcare ecosystem.

The partnership represents a strategic move for HeartSciences to embed its technology within academic institutions, potentially influencing future generations of healthcare professionals. By establishing UWE as an exclusive reference center, the company creates a validation platform for its AI-enhanced ECG solutions in both educational and research contexts. This academic endorsement could facilitate broader clinical adoption within the UK's National Health Service system, as trained professionals become familiar with the technology during their education.

HeartSciences is a healthcare information technology company advancing the use of ECG/EKGs through the integration of artificial intelligence. The company's MyoVista Insights platform is a device-agnostic, next-generation ECG management system designed to improve clinical efficiency and decision-making. Its MyoVista wavECG device is designed to deliver conventional ECG functionality while supporting on-device AI-enabled solutions. The company's website at https://www.heartsciences.com provides additional information about their technology and approach to cardiac care innovation.

The establishment of this reference center at UWE comes at a time when healthcare systems globally are seeking more efficient diagnostic tools and training methods. By integrating AI-enhanced ECG technology into academic programs, HeartSciences positions itself at the intersection of medical education and technological innovation. This partnership could serve as a model for similar collaborations with other academic institutions, potentially expanding the company's influence across multiple healthcare education systems. The validation of MyoVista Insights in both educational and research settings provides independent confirmation of the technology's utility beyond commercial applications.

For the UK healthcare system, this partnership represents an opportunity to modernize cardiac science education with cutting-edge technology. As future cardiac scientists train on the MyoVista platform, they develop familiarity with AI-enhanced diagnostic tools that may become standard in clinical practice. This educational integration could accelerate technology adoption within NHS trusts as newly trained professionals enter the workforce equipped with experience using advanced ECG systems. The reference center also creates opportunities for research collaboration that could further validate and refine the technology's applications in clinical settings.